{"transactions":[{"id":2406721,"issuer":{"id":8032,"kind":"organization","name":"Traws Pharma, Inc."},"owners":[{"id":130705,"kind":"person","name":"OLER ABRAHAM N.","position":1,"cik":"0001557372","reported_name":"OLER ABRAHAM N.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Corp Dev & Gen Counsel"}}],"security":"Restricted Stock Units","published_at":"2022-02-09T21:38:57.000Z","date":"2022-02-07","kind":"grant","acquired":true,"shares":17633,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit is convertible into one share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These restricted stock units vest over 3 years from the date of grant: 33% on the first anniversary; 33% on the second anniversary; and 34 % on the third anniversary."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"These restricted stock units vest over 3 years from the date of grant: 33% on the first anniversary; 33% on the second anniversary; and 34 % on the third anniversary."}],"balance_after":17633,"derivative":{"underlying":"Common stock","underlying_shares":17633},"source":{"system":"sec-edgar","filing":"0001179110-22-000962","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1130598/000117911022000962/edgar.xml","form_type":"4"}},{"id":2406720,"issuer":{"id":8032,"kind":"organization","name":"Traws Pharma, Inc."},"owners":[{"id":130705,"kind":"person","name":"OLER ABRAHAM N.","position":1,"cik":"0001557372","reported_name":"OLER ABRAHAM N.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Corp Dev & Gen Counsel"}}],"security":"Stock Option (right to purchase)","published_at":"2022-02-09T21:38:57.000Z","date":"2022-02-07","kind":"grant","acquired":true,"shares":54050,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options vest over three years, one-third on the first anniversary of the date of grant and thereafter in 24 equal monthly installments over the following two years."}],"balance_after":54050,"derivative":{"exercise_price":1.82,"expiration_date":"2032-02-07","underlying":"Common stock","underlying_shares":54050},"source":{"system":"sec-edgar","filing":"0001179110-22-000962","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1130598/000117911022000962/edgar.xml","form_type":"4"}},{"id":2421277,"issuer":{"id":8032,"kind":"organization","name":"Traws Pharma, Inc."},"owners":[{"id":130705,"kind":"person","name":"OLER ABRAHAM N.","position":1,"cik":"0001557372","reported_name":"OLER ABRAHAM N.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Corp Dev & Gen Counsel"}}],"security":"Common Stock","published_at":"2022-01-31T13:41:50.000Z","date":"2022-01-28","kind":"purchase","acquired":true,"shares":1500,"price":1.67,"value":2505.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The purchases reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 10,333 shares held by the Abraham Oler Living Trust U/T/A DTD 07/27/2012, of which the reporting person is a trustee."}],"balance_after":24514,"source":{"system":"sec-edgar","filing":"0001179110-22-000652","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1130598/000117911022000652/edgar.xml","form_type":"4"}},{"id":2427941,"issuer":{"id":8032,"kind":"organization","name":"Traws Pharma, Inc."},"owners":[{"id":130705,"kind":"person","name":"OLER ABRAHAM N.","position":1,"cik":"0001557372","reported_name":"OLER ABRAHAM N.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Corp Dev & Gen Counsel"}}],"security":"Common Stock","published_at":"2022-01-24T13:40:04.000Z","date":"2022-01-21","kind":"purchase","acquired":true,"shares":1500,"price":2.02,"value":3030.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The purchases reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 10,333 shares held by the Abraham Oler Living Trust U/T/A DTD 07/27/2012, of which the reporting person is a trustee."}],"balance_after":23014,"source":{"system":"sec-edgar","filing":"0001179110-22-000564","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1130598/000117911022000564/edgar.xml","form_type":"4"}},{"id":2434032,"issuer":{"id":8032,"kind":"organization","name":"Traws Pharma, Inc."},"owners":[{"id":130705,"kind":"person","name":"OLER ABRAHAM N.","position":1,"cik":"0001557372","reported_name":"OLER ABRAHAM N.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP CORP DEV & GEN COUNSEL"}}],"security":"Common Stock","published_at":"2022-01-18T14:12:56.000Z","date":"2022-01-14","kind":"purchase","acquired":true,"shares":1500,"price":2.2,"value":3300.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The purchases reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 10,333 shares held by the Abraham Oler Living Trust U/T/A DTD 07/27/2012, of which the reporting person is a trustee."}],"balance_after":21514,"source":{"system":"sec-edgar","filing":"0001415889-22-000588","document":"form4-01182022_060148.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1130598/000141588922000588/form4-01182022_060148.xml","form_type":"4"}},{"id":2439300,"issuer":{"id":8032,"kind":"organization","name":"Traws Pharma, Inc."},"owners":[{"id":130705,"kind":"person","name":"OLER ABRAHAM N.","position":1,"cik":"0001557372","reported_name":"OLER ABRAHAM N.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Corp Dev & Gen Counsel"}}],"security":"Common Stock","published_at":"2022-01-10T13:39:14.000Z","date":"2022-01-07","kind":"purchase","acquired":true,"shares":1500,"price":2.39,"value":3585.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The purchases reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 10,333 shares held by the Abraham Oler Living Trust U/T/A DTD 07/27/2012, of which the reporting person is a trustee."}],"balance_after":20014,"source":{"system":"sec-edgar","filing":"0001179110-22-000350","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1130598/000117911022000350/edgar.xml","form_type":"4"}},{"id":2498971,"issuer":{"id":8032,"kind":"organization","name":"Traws Pharma, Inc."},"owners":[{"id":130705,"kind":"person","name":"OLER ABRAHAM N.","position":1,"cik":"0001557372","reported_name":"OLER ABRAHAM N.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP CORP DEV & GEN COUNSEL"}}],"security":"Common stock","published_at":"2021-11-23T14:20:44.000Z","date":"2021-11-19","kind":"purchase","acquired":true,"shares":1000,"price":3.16,"value":3160.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 10,333 shares held by the Abraham Oler Living Trust U/T/A DTD 07/27/2012, of which the reporting person is a trustee"}],"balance_after":18514,"source":{"system":"sec-edgar","filing":"0001415889-21-005425","document":"form4-11232021_061136.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1130598/000141588921005425/form4-11232021_061136.xml","form_type":"4"}},{"id":2503329,"issuer":{"id":8032,"kind":"organization","name":"Traws Pharma, Inc."},"owners":[{"id":130705,"kind":"person","name":"OLER ABRAHAM N.","position":1,"cik":"0001557372","reported_name":"OLER ABRAHAM N.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Corp Dev & Gen Counsel"}}],"security":"Warrant (right to purchase)","published_at":"2021-11-19T13:45:01.000Z","date":"2021-11-18","kind":"other","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The warrants were acquired in the November 2019 public offering, by Onconova Therapeutics, Inc, of units which included one share of common stock and one warrant."}],"balance_after":0,"derivative":{"exercise_price":3,"exercise_date":"2019-11-25","expiration_date":"2024-11-25","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001179110-21-010259","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1130598/000117911021010259/edgar.xml","form_type":"4"}},{"id":2503328,"issuer":{"id":8032,"kind":"organization","name":"Traws Pharma, Inc."},"owners":[{"id":130705,"kind":"person","name":"OLER ABRAHAM N.","position":1,"cik":"0001557372","reported_name":"OLER ABRAHAM N.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Corp Dev & Gen Counsel"}}],"security":"Common Stock","published_at":"2021-11-19T13:45:01.000Z","date":"2021-11-18","kind":"other","acquired":true,"shares":5000,"price":3,"value":15000.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 9,333 shares held by the Abraham Oler Living Trust U/T/A DTD 07/27/2012, of which the reporting person is a trustee."}],"balance_after":17514,"source":{"system":"sec-edgar","filing":"0001179110-21-010259","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1130598/000117911021010259/edgar.xml","form_type":"4"}},{"id":2556885,"issuer":{"id":8032,"kind":"organization","name":"Traws Pharma, Inc."},"owners":[{"id":130705,"kind":"person","name":"OLER ABRAHAM N.","position":1,"cik":"0001557372","reported_name":"OLER ABRAHAM N.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Corp Dev & Gen Counsel"}}],"security":"Common Stock","published_at":"2021-09-29T12:27:42.000Z","date":"2021-09-28","kind":"purchase","acquired":true,"shares":2381,"price":4.2,"value":10000.2,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 4,334 shares held by the Abraham Oler Living Trust U/T/A DTD 07/27/2012, of which the reporting person is a trustee"}],"balance_after":12515,"source":{"system":"sec-edgar","filing":"0001179110-21-008982","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1130598/000117911021008982/edgar.xml","form_type":"4"}},{"id":2615471,"issuer":{"id":8032,"kind":"organization","name":"Traws Pharma, Inc."},"owners":[{"id":130705,"kind":"person","name":"OLER ABRAHAM N.","position":1,"cik":"0001557372","reported_name":"OLER ABRAHAM N.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Corp Dev & Gen Counsel"}}],"security":"Restricted Stock Units","published_at":"2021-08-04T23:12:24.000Z","date":"2021-08-02","kind":"grant","acquired":true,"shares":13400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit is convertible into one share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These restricted stock units vest over 3 years from the date of grant: 33% on the first anniversary; 33% on the second anniversary; and 34 % on the third anniversary."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"These restricted stock units vest over 3 years from the date of grant: 33% on the first anniversary; 33% on the second anniversary; and 34 % on the third anniversary."}],"balance_after":13400,"derivative":{"underlying":"Common stock","underlying_shares":13400},"source":{"system":"sec-edgar","filing":"0001179110-21-007922","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1130598/000117911021007922/edgar.xml","form_type":"4"}},{"id":2615470,"issuer":{"id":8032,"kind":"organization","name":"Traws Pharma, Inc."},"owners":[{"id":130705,"kind":"person","name":"OLER ABRAHAM N.","position":1,"cik":"0001557372","reported_name":"OLER ABRAHAM N.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Corp Dev & Gen Counsel"}}],"security":"Stock Option (right to purchase)","published_at":"2021-08-04T23:12:24.000Z","date":"2021-08-02","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options vest over three years, one-third on the first anniversary of the date of grant and thereafter in 24 equal monthly installments over the following two years."}],"balance_after":40000,"derivative":{"exercise_price":5.19,"expiration_date":"2031-08-02","underlying":"Common stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001179110-21-007922","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1130598/000117911021007922/edgar.xml","form_type":"4"}},{"id":2846691,"issuer":{"id":8032,"kind":"organization","name":"Traws Pharma, Inc."},"owners":[{"id":130705,"kind":"person","name":"OLER ABRAHAM N.","position":1,"cik":"0001557372","reported_name":"OLER ABRAHAM N.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Corp Dev & Gen Counsel"}}],"security":"Stock Appreciation Right","published_at":"2021-02-19T22:29:17.000Z","date":"2021-02-17","kind":"grant","acquired":true,"shares":208000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These stock appreciation rights vest over three years, one-third on the first anniversary of the date of grant and thereafter in 24 equal monthly installments over the following two years."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F2","text":"These stock appreciation rights represent the right to receive a cash payment equal to the excess, if any, of (i) the fair market value of each underlying share of the Company's common stock, determined on the date of exercise minus (ii) the exercise price; provided, that in no event may the cash payment for each stock appreciation right exceed $1.03, which is the maximum price per share of $2.54, minus the base amount of $1.51, subject to adjustment in accordance with the terms of the award agreement."}],"balance_after":208000,"derivative":{"exercise_price":1.51,"expiration_date":"2031-02-17","underlying":"Common Stock","underlying_shares":208000},"source":{"system":"sec-edgar","filing":"0001179110-21-002008","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1130598/000117911021002008/edgar.xml","form_type":"4"}},{"id":2855473,"issuer":{"id":8032,"kind":"organization","name":"Traws Pharma, Inc."},"owners":[{"id":130705,"kind":"person","name":"OLER ABRAHAM N.","position":1,"cik":"0001557372","reported_name":"OLER ABRAHAM N.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Corp Dev & Gen Counsel"}}],"security":"Common Stock","published_at":"2021-02-17T13:57:59.000Z","date":"2021-02-16","kind":"purchase","acquired":true,"shares":12000,"price":1,"value":12000.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 65,000 shares held by the Abraham Oler Living Trust U/T/A DTD 07/27/2012, of which the reporting person is a trustee."}],"balance_after":152000,"source":{"system":"sec-edgar","filing":"0001179110-21-001785","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1130598/000117911021001785/edgar.xml","form_type":"4"}},{"id":2946914,"issuer":{"id":8032,"kind":"organization","name":"Traws Pharma, Inc."},"owners":[{"id":130705,"kind":"person","name":"OLER ABRAHAM N.","position":1,"cik":"0001557372","reported_name":"OLER ABRAHAM N.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Corp Dev & Gen Counsel"}}],"security":"Common Stock","published_at":"2020-12-14T14:00:34.000Z","date":"2020-12-11","kind":"purchase","acquired":true,"shares":30000,"price":0.32,"value":9600.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 65,000 shares held by the Abraham Oler Living Trust U/T/A DTD 07/27/2012, of which the reporting person is a trustee."}],"balance_after":140000,"source":{"system":"sec-edgar","filing":"0001179110-20-011839","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1130598/000117911020011839/edgar.xml","form_type":"4"}},{"id":2964492,"issuer":{"id":8032,"kind":"organization","name":"Traws Pharma, Inc."},"owners":[{"id":130705,"kind":"person","name":"OLER ABRAHAM N.","position":1,"cik":"0001557372","reported_name":"OLER ABRAHAM N.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Corp Dev & Gen Counsel"}}],"security":"Common Stock","published_at":"2020-11-30T22:09:47.000Z","date":"2020-11-25","kind":"purchase","acquired":true,"shares":20000,"price":0.256,"value":5120.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 35,000 shares held by the Abraham Oler Living Trust U/T/A DTD 07/27/2012, of which the reporting person is a trustee."}],"balance_after":110000,"source":{"system":"sec-edgar","filing":"0001179110-20-011469","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1130598/000117911020011469/edgar.xml","form_type":"4"}},{"id":3085077,"issuer":{"id":8032,"kind":"organization","name":"Traws Pharma, Inc."},"owners":[{"id":130705,"kind":"person","name":"OLER ABRAHAM N.","position":1,"cik":"0001557372","reported_name":"OLER ABRAHAM N.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Corp Dev & Gen Counsel"}}],"security":"Stock Appreciation Right","published_at":"2020-07-10T21:51:18.000Z","date":"2020-07-09","kind":"grant","acquired":true,"shares":375600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These stock appreciation rights vest over three years, one-third on the first anniversary of the date of grant and thereafter in 24 equal monthly installments over the following two years."}],"balance_after":375600,"derivative":{"exercise_price":0.56,"expiration_date":"2030-07-09","underlying":"Common Stock","underlying_shares":375600},"source":{"system":"sec-edgar","filing":"0001179110-20-008213","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1130598/000117911020008213/edgar.xml","form_type":"4"}},{"id":3141111,"issuer":{"id":8032,"kind":"organization","name":"Traws Pharma, Inc."},"owners":[{"id":130705,"kind":"person","name":"OLER ABRAHAM N.","position":1,"cik":"0001557372","reported_name":"OLER ABRAHAM N.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Corp Dev & Gen Counsel"}}],"security":"Common Stock","published_at":"2020-05-20T13:19:29.000Z","date":"2020-05-19","kind":"purchase","acquired":true,"shares":15000,"price":0.37,"value":5550.0,"ownership":{"direct":true},"balance_after":90000,"source":{"system":"sec-edgar","filing":"0001179110-20-006359","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1130598/000117911020006359/edgar.xml","form_type":"4"}},{"id":3331476,"issuer":{"id":8032,"kind":"organization","name":"Traws Pharma, Inc."},"owners":[{"id":130705,"kind":"person","name":"OLER ABRAHAM N.","position":1,"cik":"0001557372","reported_name":"OLER ABRAHAM N.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP Corp Dev & Gen Counsel"}}],"security":"Stock Option (right to purchase)","published_at":"2019-12-26T14:08:44.000Z","date":"2019-12-20","kind":"grant","acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options vest over three years, one-third on the first anniversary of the date of grant and thereafter in 24 equal monthly installments over the following two years."}],"balance_after":60000,"derivative":{"exercise_price":0.31,"expiration_date":"2029-12-20","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001179110-19-013140","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1130598/000117911019013140/edgar.xml","form_type":"4"}},{"id":3358972,"issuer":{"id":8032,"kind":"organization","name":"Traws Pharma, Inc."},"owners":[{"id":130705,"kind":"person","name":"OLER ABRAHAM N.","position":1,"cik":"0001557372","reported_name":"OLER ABRAHAM N.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP Corp Dev & Gen Counsel"}}],"security":"Warrant (right to purchase)","published_at":"2019-11-26T12:46:57.000Z","date":"2019-11-25","kind":"purchase","acquired":true,"shares":75000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The common stock and warrants were acquired in a public offering, by Onconova Therapeutics, Inc, of units which included one share of common stock and one warrant. The public offering price for each unit was $0.20."}],"balance_after":75000,"derivative":{"exercise_price":0.2,"exercise_date":"2019-11-25","expiration_date":"2024-11-25","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001179110-19-012054","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1130598/000117911019012054/edgar.xml","form_type":"4"}},{"id":3358971,"issuer":{"id":8032,"kind":"organization","name":"Traws Pharma, Inc."},"owners":[{"id":130705,"kind":"person","name":"OLER ABRAHAM N.","position":1,"cik":"0001557372","reported_name":"OLER ABRAHAM N.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP Corp Dev & Gen Counsel"}}],"security":"Common Stock","published_at":"2019-11-26T12:46:57.000Z","date":"2019-11-25","kind":"purchase","acquired":true,"shares":75000,"price":0.2,"value":15000.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The common stock and warrants were acquired in a public offering, by Onconova Therapeutics, Inc, of units which included one share of common stock and one warrant. The public offering price for each unit was $0.20."}],"balance_after":75000,"source":{"system":"sec-edgar","filing":"0001179110-19-012054","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1130598/000117911019012054/edgar.xml","form_type":"4"}}]}